BDBM72340 (2S)-2-(benzenesulfonamido)-3-methyl-butyric acid [2-keto-2-[(2-methoxydibenzofuran-3-yl)amino]ethyl] ester::(2S)-2-(benzenesulfonamido)-3-methylbutanoic acid [2-[(2-methoxy-3-dibenzofuranyl)amino]-2-oxoethyl] ester::MLS000393930::SMR000247370::[2-[(2-methoxydibenzofuran-3-yl)amino]-2-oxidanylidene-ethyl] (2S)-3-methyl-2-(phenylsulfonylamino)butanoate::[2-[(2-methoxydibenzofuran-3-yl)amino]-2-oxoethyl] (2S)-2-(benzenesulfonamido)-3-methylbutanoate::cid_2469069
SMILES COc1cc2c(cc1NC(=O)COC(=O)[C@@H](NS(=O)(=O)c1ccccc1)C(C)C)oc1ccccc21
InChI Key InChIKey=KXTOONSIFLGUPE-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 72340
TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development
US Patent
Glaxosmithkline Intellectual Property Development
US Patent
Affinity DataIC50: 1.26nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
